High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

• Main Authors: Bjartell Anders (Author), Uhlén Mathias (Author), Ulmert David (Author), Gaber Alexander (Author), Jonsson Liv (Author), Jirström Karin (Author)
• Format: Book
• Published: BMC, 2011-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>High expression of the RNA-binding protein RBM3 has previously been found to be associated with good prognosis in breast cancer, ovarian cancer, malignant melanoma and colorectal cancer. The aim of this study was to examine the progn...